Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer
Alessandro Sciarra(Policlinico Umberto I), Martina Maggi(Policlinico Umberto I), Alessandro Gentilucci(Policlinico Umberto I), Susanna Cattarino(Policlinico Umberto I), Stefano Salciccia(Policlinico Umberto I), Susanna Scarpa(Sapienza University of Rome), Gian Piero Ricciuti(Policlinico Umberto I), Ida Silvestri(Azienda Ospedaliera Sant'Andrea), Magnus Von Heland(Policlinico Umberto I), Viviana Frantellizzi(Sapienza University of Rome), Francesco Del Giudice(Sapienza University of Rome), Antonio Gatto(Policlinico Umberto I)
Cited by 40
Related Papers
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non–muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection
|European Urology|2019|212
Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis
|European Urology Oncology|2020|173
Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management—Current Trends and Future Perspectives
|Diagnostics|2021|158